Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

NCT07062354 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Head &Amp; Neck Cancer
Head &Amp; Neck Squamous Cell Carcinoma

Interventions

DRUG: Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]